tiprankstipranks
Sanofi (GB:0O59)
LSE:0O59
Holding GB:0O59?
Track your performance easily

Sanofi (0O59) Income Statement

9 Followers

Sanofi Income Statement

Last quarter (Q4 2023), Sanofi's total revenue was €―, a decrease of -100.00% from the same quarter last year. In Q4, Sanofi's net income was €―. See Sanofi’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 23.88B€ 46.44B€ 45.39B€ 39.17B€ 37.37B€ 36.13B
Cost of Revenue
€ 7.08B€ 14.24B€ 13.70B€ 12.26B€ 12.16B€ 11.98B
Gross Profit
€ 16.80B€ 32.21B€ 31.69B€ 26.92B€ 25.21B€ 24.15B
Operating Expense
€ 9.88B€ 24.00B€ 19.81B€ 18.64B€ 18.21B€ 23.69B
Operating Income
€ 6.92B€ 8.20B€ 6.71B€ 6.92B€ 5.63B€ 460.00M
Net Non Operating Interest Income Expense
€ -128.00M€ -722.00M€ 288.00M€ 40.00M€ 53.00M€ 169.00M
Other Income Expense
€ -2.77B€ -1.16B€ -1.17B€ -15.85B€ -15.81B€ -6.55B
Pretax Income
€ 4.03B€ 7.15B€ 10.42B€ 24.57B€ 28.40B€ 7.60B
Tax Provision
€ 764.00M€ 1.60B€ 2.01B€ 1.56B€ 1.81B€ 139.00M
Earnings From Equity Interest Net Of Tax
€ 35.00M-€ 68.00M€ 106.00M€ 8.67B€ 3.71B
Net Income Common Stockholders
€ 3.25B€ 5.40B€ 8.37B€ 6.22B€ 12.29B€ 7.39B
Basic EPS
-€ 4.31-€ 4.97€ 19.64€ 4.57
Diluted EPS
-€ 4.30-€ 4.95€ 19.54€ 4.54
Basic Average Shares
-€ 1.25B€ 1.25B€ 1.25B€ 1.25B€ 1.25B
Diluted Average Shares
-€ 1.26B€ 1.25B€ 1.25B€ 1.25B€ 1.25B
Dividend Per Share
-€ 3.76€ 3.91---
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
€ 16.96B€ 38.24B€ 33.51B€ 30.90B€ 30.37B€ 35.67B
Net Income From Continuing And Discontinued Operation
€ 3.25B€ 5.40B€ 8.37B€ 6.22B€ 12.29B€ 7.39B
Normalized Income
€ 5.38B-----
Interest Expense
€ 204.00M-----
EBIT
€ 4.23B-€ 10.88B€ 8.19B€ 14.21B€ 4.94B
EBITDA
€ 5.15B-€ 14.30B€ 11.54B€ 17.88B€ 6.97B
Currency in EUR

Sanofi Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis